X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Strides Arcolab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs STRIDES SHASUN LTD - Comparison Results

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE STRIDES SHASUN LTD TTK HEALTHCARE/
STRIDES SHASUN LTD
 
P/E (TTM) x 22.8 44.2 51.6% View Chart
P/BV x 7.7 1.1 698.1% View Chart
Dividend Yield % 0.4 0.9 42.0%  

Financials

 TTK HEALTHCARE   STRIDES SHASUN LTD
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
STRIDES SHASUN LTD
Mar-17
TTK HEALTHCARE/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs6631,275 52.0%   
Low Rs399918 43.5%   
Sales per share (Unadj.) Rs535.6389.6 137.5%  
Earnings per share (Unadj.) Rs15.928.0 57.0%  
Cash flow per share (Unadj.) Rs20.048.9 41.0%  
Dividends per share (Unadj.) Rs4.004.50 88.9%  
Dividend yield (eoy) %0.80.4 183.5%  
Book value per share (Unadj.) Rs137.6303.1 45.4%  
Shares outstanding (eoy) m7.7789.42 8.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.02.8 35.2%   
Avg P/E ratio x33.339.2 85.0%  
P/CF ratio (eoy) x26.522.4 118.3%  
Price / Book Value ratio x3.93.6 106.7%  
Dividend payout %25.116.1 155.9%   
Avg Mkt Cap Rs m4,12798,036 4.2%   
No. of employees `0001.75.8 29.4%   
Total wages/salary Rs m6075,881 10.3%   
Avg. sales/employee Rs Th2,436.76,005.9 40.6%   
Avg. wages/employee Rs Th355.21,014.0 35.0%   
Avg. net profit/employee Rs Th72.5431.2 16.8%   
INCOME DATA
Net Sales Rs m4,16234,834 11.9%  
Other income Rs m611,686 3.6%   
Total revenues Rs m4,22336,520 11.6%   
Gross profit Rs m1976,428 3.1%  
Depreciation Rs m321,872 1.7%   
Interest Rs m302,269 1.3%   
Profit before tax Rs m1973,973 5.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m04 0.0%   
Extraordinary Inc (Exp) Rs m0-1,006 0.0%   
Tax Rs m73470 15.5%   
Profit after tax Rs m1242,501 5.0%  
Gross profit margin %4.718.5 25.7%  
Effective tax rate %37.011.8 312.9%   
Net profit margin %3.07.2 41.5%  
BALANCE SHEET DATA
Current assets Rs m1,62938,165 4.3%   
Current liabilities Rs m1,05830,402 3.5%   
Net working cap to sales %13.722.3 61.6%  
Current ratio x1.51.3 122.7%  
Inventory Days Days3077 38.5%  
Debtors Days Days34104 32.2%  
Net fixed assets Rs m55637,639 1.5%   
Share capital Rs m78894 8.7%   
"Free" reserves Rs m87826,210 3.4%   
Net worth Rs m1,06927,105 3.9%   
Long term debt Rs m15916,377 1.0%   
Total assets Rs m2,39981,168 3.0%  
Interest coverage x7.62.8 275.5%   
Debt to equity ratio x0.10.6 24.6%  
Sales to assets ratio x1.70.4 404.2%   
Return on assets %6.45.9 109.1%  
Return on equity %11.69.2 125.6%  
Return on capital %18.512.1 153.1%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m3313,465 0.2%   
Fx outflow Rs m634,076 1.6%   
Net fx Rs m-309,389 -0.3%   
CASH FLOW
From Operations Rs m1272,881 4.4%  
From Investments Rs m-146-7,051 2.1%  
From Financial Activity Rs m223,382 0.6%  
Net Cashflow Rs m3-788 -0.3%  

Share Holding

Indian Promoters % 65.4 27.7 236.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 37.8 9.8%  
FIIs % 5.2 8.6 60.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 25.9 99.6%  
Shareholders   12,723 56,241 22.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   WOCKHARDT LTD.  FULFORD INDIA  MERCK LTD  DIVIS LABORATORIES  UNICHEM LAB  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Downtrend, BOB-Vijaya-Dena Merger, and Top Stocks in Action Today(Pre-Open)

Share markets in India continued their momentum and ended in red yesterday. Sectoral indices traded in red, with stocks in the realty sector, power sector and PSU sector leading the losses.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

STRIDES SHASUN LTD Announces Quarterly Results (1QFY19); Net Profit Down 57.5% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, STRIDES SHASUN LTD has posted a net profit of Rs 38 m (down 57.5% YoY). Sales on the other hand came in at Rs 7 bn (down 21.2% YoY). Read on for a complete analysis of STRIDES SHASUN LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Hurricanes Threaten Oil Spike, but the Saudis are Selling...(Vivek Kaul's Diary)

Sep 6, 2018

Oil prices are rising and could go even more higher amid rising tensions in Middle East.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 18, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS